Mental Health

Artificial Intelligence (AI) in Healthcare Market to Grow at 38.2% CAGR by 2031 | SkyQuest Technology

WESTFORD, Mass., June 24, 2024 /PRNewswire/ -- As per SkyQuest, the Global Artificial Intelligence in Healthcare Market size was valued at USD…

5 months ago

Safe Supply Streaming Corp. Announces Resignation of Board Member

Toronto, Ontario--(Newsfile Corp. - June 21, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or…

5 months ago

Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders

Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July…

5 months ago

iRCM Inc: Trusted Experts in End-to-End Medical Billing and Credentialing Services Nationwide

"Healthcare providers often find themselves balancing the demands of patient care with the complexities of medical billing and credentialing," said…

5 months ago

Syra Health to Deliver Fourth Training for Maricopa County Department of Public Health in Arizona

CARMEL, Ind., June 20, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology…

5 months ago

MindBio Therapeutics Reports Sustained Antidepressant Response from MB22001 in Depression Clinical Trials

Rapid, robust, and clinically significant reduction in depression symptomsTrials of MB22001 show substantial improvements in mood, energy, creativity, wellbeing, depression…

5 months ago

New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Family Building Benefits

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health…

5 months ago

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia

HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced…

5 months ago

Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment

Vancouver, Canada, June 20, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

5 months ago

MediOrbis(TM) Partners with Healthyr(TM) to Offer Proven Engagement, Longitudinal Care and Specialty

MediOrbis TM Partners with Healthyr to Offer Proven Engagement, Longitudinal Care and Specialty Telehealth Services to Payers and Providers CLEVELAND,…

5 months ago